For over 60 years, Dr Falk Pharma has driven innovation in
digestive and metabolic diseases. At Dr Falk, we’ve believed in the power of shared
understanding since the beginning. Working alongside clinicians, researchers and patients alike.
In 1967, scientists and clinicians gathered at the first
Falk Symposium a true meeting of minds, fostering a real and lasting network of
collaboration. Today there have been over 200 Symposia across 100 countries.
These gatherings – the connections made, the knowledge shared – define
Herbert’s legacy. We carry on that legacy today, founding our mission three pillars:
Collaboration, Formulation, and Destination.
Dr Falk Pharma drives innovation, developing therapies that
work for people, not just diseases. Our range of formulations is thoughtfully
designed to fit into real lives, because treatments only work when patients
Whether the disease is in the gut or the liver, we develop
treatments that target the right place, at the right time, in the right
Dr Falk also offer a wide range of educational resources for
HCPs and patients to help manage their disease.
View the resources available along with the meetings by
visiting the Dr Falk website.
Together we know more, Together we do more
Visit their website >
Jorveza is an effective treatment for induction and maintenance of remission in eosinophilic oesophagitis
Learn more about the event